ESR2 and cancer: Taken together, our data demonstrate that, in BLM melanoma cells, ERβ activation reduces cell growth, through the modulation of cell cycle related proteins, and that this antitumor activity is associated with the reversal of the global DNA hypomethylation status of these cancer cells.